乳糜泻药物市场：按药物、类型、最终用户、适应症分类 - 全球预测 2023-2030

预计2023年全球乳糜泻药物市场将达到14,2125万美元，复合年增长率为10.52%，大幅成长，2030年将达到28,7559万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球乳糜泻药物市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.乳糜泻治疗药物的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球乳糜泻治疗药物市场的阻碍因素和影响为何？

3.在预测期内，全球乳糜泻治疗药物市场需要投资哪些产品/细分市场/应用/领域？

4.全球乳糜泻药物市场的竞争策略为何？

5. 全球乳糜泻药物市场的技术趋势和法律规范是什么？

6.全球乳糜泻治疗药物市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入乳糜泻药物全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 乳糜泻盛行率增加
    • 对含麸质食品和即食包装食品的依赖增加
    • 增加政府和私部门对乳糜泻认识的支持
  • 抑制因素
    • 可用的治疗选择有限
  • 机会
    • 活性化旨在引进先进乳糜泻治疗药物的研发活动
    • 医疗保健领域的技术进步与现代化
  • 任务
    • 政府对药品审批的严格法规
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章乳糜泻治疗药物市场（按药物）

• 一线治疗
• 二次处理

第7章乳糜泻治疗药物市场：按类型

• 类固醇和免疫抑制剂
• 治疗性疫苗
• 维生素和营养补充食品

第8章乳糜泻治疗药物市场：依最终使用者分类

• 临床研究组织
• 医院和诊所
• 研究和学术机构

第9章乳糜泻治疗药物市场（按适应症）

• 厌食症
• 腹胀
• 腹泻
• 扩张
• 不适
• 气体

第10章美洲乳糜泻药物市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第11章亚太地区乳糜泻药物市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第12章欧洲、中东和非洲乳糜泻药物市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第13章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

• 讨论指南
• 关于许可证和定价

The Global Celiac Disease Drugs Market is forecasted to grow significantly, with a projected USD 1,421.25 million in 2023 at a CAGR of 10.52% and expected to reach a staggering USD 2,875.59 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Celiac Disease Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Celiac Disease Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug, market is studied across First Line of Treatment and Second Line of Treatment. The Second Line of Treatment is projected to witness significant market share during forecast period.

Based on Type, market is studied across Steroids & Immunosuppressive Drugs, Therapeutic Vaccines, and Vitamins & Dietary Supplements. The Vitamins & Dietary Supplements is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Clinical Research Organizations, Hospitals & Clinics, and Research & Academic Institutes. The Clinical Research Organizations is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Anorexia, Bloating, Diarrhea, Distension, Fatigue, and Gas. The Distension is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Celiac Disease Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Celiac Disease Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Celiac Disease Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Celiac Disease Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Celiac Disease Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Celiac Disease Drugs Market?

6. What is the market share of the leading vendors in the Global Celiac Disease Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Celiac Disease Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Celiac Disease Drugs Market, by Drug, 2022 vs 2030
• 4.3. Celiac Disease Drugs Market, by Type, 2022 vs 2030
• 4.4. Celiac Disease Drugs Market, by End-User, 2022 vs 2030
• 4.5. Celiac Disease Drugs Market, by Indication, 2022 vs 2030
• 4.6. Celiac Disease Drugs Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growth in prevalence of celiac disease
    • 5.1.1.2. Rising dependence of gluten containing and ready-to-eat packaged food
    • 5.1.1.3. Increase government and private organizations support towards celiac disease awareness
  • 5.1.2. Restraints
    • 5.1.2.1. Restricted availability of treatment options
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D activities to introduce advanced celiac disease drugs
    • 5.1.3.2. Technological advancements and increasing modernization in the healthcare sector
  • 5.1.4. Challenges
    • 5.1.4.1. Strict government regulations for drug approval
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Celiac Disease Drugs Market, by Drug

• 6.1. Introduction
• 6.2. First Line of Treatment
• 6.3. Second Line of Treatment

7. Celiac Disease Drugs Market, by Type

• 7.1. Introduction
• 7.2. Steroids & Immunosuppressive Drugs
• 7.3. Therapeutic Vaccines
• 7.4. Vitamins & Dietary Supplements

8. Celiac Disease Drugs Market, by End-User

• 8.1. Introduction
• 8.2. Clinical Research Organizations
• 8.3. Hospitals & Clinics
• 8.4. Research & Academic Institutes

9. Celiac Disease Drugs Market, by Indication

• 9.1. Introduction
• 9.2. Anorexia
• 9.3. Bloating
• 9.4. Diarrhea
• 9.5. Distension
• 9.6. Fatigue
• 9.7. Gas

10. Americas Celiac Disease Drugs Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Celiac Disease Drugs Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Celiac Disease Drugs Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. CELIAC DISEASE DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. CELIAC DISEASE DRUGS MARKET SIZE, 2022 VS 2030
• FIGURE 3. CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2022 VS 2030 (%)
• FIGURE 5. CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 6. CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 8. CELIAC DISEASE DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. CELIAC DISEASE DRUGS MARKET DYNAMICS
• FIGURE 10. CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. CELIAC DISEASE DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. CELIAC DISEASE DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CELIAC DISEASE DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CELIAC DISEASE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 5. CELIAC DISEASE DRUGS MARKET SIZE, BY FIRST LINE OF TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CELIAC DISEASE DRUGS MARKET SIZE, BY SECOND LINE OF TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. CELIAC DISEASE DRUGS MARKET SIZE, BY STEROIDS & IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CELIAC DISEASE DRUGS MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CELIAC DISEASE DRUGS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 12. CELIAC DISEASE DRUGS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. CELIAC DISEASE DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CELIAC DISEASE DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 16. CELIAC DISEASE DRUGS MARKET SIZE, BY ANOREXIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. CELIAC DISEASE DRUGS MARKET SIZE, BY BLOATING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. CELIAC DISEASE DRUGS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. CELIAC DISEASE DRUGS MARKET SIZE, BY DISTENSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. CELIAC DISEASE DRUGS MARKET SIZE, BY FATIGUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. CELIAC DISEASE DRUGS MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 36. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. CANADA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 58. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. CHINA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 62. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 131. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. ITALY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 147. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. POLAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 151. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. QATAR CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM CELIAC DISEASE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. CELIAC DISEASE DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 191. CELIAC DISEASE DRUGS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 192. CELIAC DISEASE DRUGS MARKET LICENSE & PRICING